Contribute Try STAT+ Today

Rise and shine, everyone, another busy day is on the way. How could it be otherwise? Despite empty streets, the usual buzz of activity is under way. After all, the world is still spinning, as wobbly as it may seem sometimes. So please join us as we reach for the ritualistic cup of stimulation and get cracking. On that note, here are a few items of interest we have assembled to help you along. Hope your day is manageable and, as always, stay safe.

European Commissioner for Internal Market and Services Thierry Breton says that European Union countries will have access to the medicines they need to care for coronavirus sufferers and that pharmaceutical companies were doubling production to address shortages, Reuters writes. Many countries around the world rely on China, the source of the outbreak, for drug ingredients and now find themselves grappling with how to avoid shortages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.